Evidence for erythropoietin as a molecular targeting agent

被引:18
作者
Leyland-Jones, B [1 ]
机构
[1] McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada
关键词
D O I
10.1053/sonc.2002.34067
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:145 / 154
页数:10
相关论文
共 108 条
[21]   Molecular mechanisms of erythropoietin signaling [J].
Cheung, JY ;
Miller, BA .
NEPHRON, 2001, 87 (03) :215-222
[22]  
Chin H, 1998, BLOOD, V91, P3734
[23]   COORDINATE EXPRESSION AND DEVELOPMENTAL ROLE OF ID2 PROTEIN AND TAL1/E2A HETERODIMER IN ERYTHROID PROGENITOR DIFFERENTIATION [J].
CONDORELLI, G ;
VITELLI, L ;
VALTIERI, M ;
MARTA, I ;
MONTESORO, E ;
LULLI, V ;
BAER, R ;
PESCHLE, C .
BLOOD, 1995, 86 (01) :164-175
[24]  
CROSSLEY M, 1994, J BIOL CHEM, V269, P15440
[25]   The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase [J].
Damen, JE ;
Liu, L ;
Rosten, P ;
Humphries, RK ;
Jefferson, AB ;
Majerus, PW ;
Krystal, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) :1689-1693
[26]  
DAMEN JE, 1993, BLOOD, V81, P3204
[27]  
DAMEN JE, 1993, BLOOD, V82, P2296
[28]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[29]   Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study [J].
Demetri, GD ;
Kris, M ;
Wade, J ;
Degos, L ;
Cella, D .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3412-3425
[30]   Exploring the metabolic and genetic control of gene expression on a genomic scale [J].
DeRisi, JL ;
Iyer, VR ;
Brown, PO .
SCIENCE, 1997, 278 (5338) :680-686